The transcription factor IRF4 regulates immunoglobulin class switch recombination and plasma cell differentiation. Its differing concentrations appear to regulate mutually antagonistic programs of B and plasma cell gene expression. We show IRF4 to be also required for generation of germinal center (GC) B cells. Its transient expression in vivo induced the expression of key GC genes including Bcl6 and Aicda. In contrast, sustained and higher concentrations of IRF4 promoted the generation of plasma cells while antagonizing the GC fate. IRF4 cobound with the transcription factors PU.1 or BATF to Ets or AP-1 composite motifs, associated with genes involved in B cell activation and the GC response. At higher concentrations, IRF4 binding shifted to interferon sequence response motifs; these enriched for genes involved in plasma cell differentiation. Our results support a model of ''kinetic control'' in which signaling-induced dynamics of IRF4 in activated B cells control their cell-fate outcomes.
SUMMARY
The transcription factor IRF4 regulates immunoglobulin class switch recombination and plasma cell differentiation. Its differing concentrations appear to regulate mutually antagonistic programs of B and plasma cell gene expression. We show IRF4 to be also required for generation of germinal center (GC) B cells. Its transient expression in vivo induced the expression of key GC genes including Bcl6 and Aicda. In contrast, sustained and higher concentrations of IRF4 promoted the generation of plasma cells while antagonizing the GC fate. IRF4 cobound with the transcription factors PU.1 or BATF to Ets or AP-1 composite motifs, associated with genes involved in B cell activation and the GC response. At higher concentrations, IRF4 binding shifted to interferon sequence response motifs; these enriched for genes involved in plasma cell differentiation. Our results support a model of ''kinetic control'' in which signaling-induced dynamics of IRF4 in activated B cells control their cell-fate outcomes.
INTRODUCTION
Germinal Center (GC) B cells and plasma cells (PC) develop following the activation of naive B cells with cognate antigen in combination with signals from T helper cells and dendritic cells (Goodnow et al., 2010) . These distinct cellular states, GC and PC, perform key roles in humoral immunity against microbes by enabling generation of high-affinity antibodies and their robust expression and secretion, respectively. Considerable progress has been achieved in the analysis of transcription factors that are required for the generation of GC B cells and their plasma cell counterparts; however, the molecular mechanisms by which such regulators orchestrate these alternative cellular states and the transition from the GC to the PC differentiation programs are incompletely understood.
The identity and function of plasma cells is dependent on the transcription factors Blimp1, Xbp1, and IRF4 (Nutt et al., 2011) . In contrast, GC B cell development requires the transcription factors Bcl6, Pax5, Bach2, and Obf1 (Nutt et al., 2011) . Blimp1 and Bcl6 function to counter regulate each other's expression. This reciprocal negative feedback is considered to play a major role in stabilizing the alternate programs of gene expression.
We have proposed that the transcription factor IRF4 is a pivotal regulator of B cell-fate dynamics upon antigen encounter (Sciammas et al., 2006 . This is based on our findings that IRF4 is required for class switch recombination (CSR) and plasma cell differentiation. It does so by upregulating AID and Blimp1 expression, respectively. We have demonstrated, by using a variety of approaches, that differing IRF4 concentrations underlie the generation of these alternative cell states. These experimental analyses have led to the formulation of a ''kinetic control'' model for the regulation of B cell-fate dynamics spanning the CSR and plasma-cell states ; see also Muto et al., 2010) . According to this model, the rate of accumulation of IRF4 induced by the BCR determines the duration for which such a cell expresses AID and therefore can undergo CSR and also somatic hypermutation (SHM). Increased expression of IRF4 beyond a critical threshold results in IRF4 activation of the Prdm1 (encoding Blimp1) locus and terminal differentiation into a plasma cell. This is accompanied by repression of Aicda (encoding AID) expression and CSR, as well as SHM. However, it remains to be determined whether this regulatory model is applicable to T-dependent B cell responses in vivo. It has been suggested that IRF4 is dispensable for the GC response in vivo (Klein et al., 2006) . However, this conclusion was based on the use of a conditional allele of IRF4 whose deletion is initiated after antigen encounter, raising the possibility that IRF4 protein was not sufficiently depleted in precursors of GC B cells in these mice. Therefore, we sought to address the role of IRF4 in regulating generation of GC B cells by using alternative genetic strategies.
IRF4 is a member of the IRF superfamily of transcription factors most highly related to IRF8 (Eisenbeis et al., 1995) . Although IRF8 is expressed in activated and GC B cells, it has been shown to be dispensable for antigen-dependent B cell responses (Feng et al., 2011) . IRF4 and IRF8 bind with much lower affinity to the GAAA motif contained within the canonical interferon sequence response element (ISRE). Instead they are recruited to high affinity Ets-IRF composite motifs (EICE) through their interaction with the transcription factors PU.1 or SpiB (Brass et al., 1999; Eisenbeis et al., 1995) . The latter are related Ets family members that play key roles in B cell activation and GC B cell function (GarrettSinha et al., 2001; Su et al., 1997) . Recently IRF4 and IRF8 have shown to cooperatively assemble with BATF containing AP-1 complexes on composite AP-1-IRF (AICE) motifs (Glasmacher et al., 2012) . Intriguingly, IRF4 appears to activate the Prdm1 (Blimp1) locus by binding to a site within a conserved intronic sequence that does not contain an EICE motif nor is associated with PU.1 cobinding (Sciammas et al., 2006) . These results raised the possibility that alternate modes of IRF4 genome targeting i.e., PU.1 or SpiB dependent and Ets factor independent may be important in regulating distinct states of gene expression, GC versus PC, within activated B cells.
Herein, by using distinct genetic strategies we demonstrate that IRF4 regulates the generation of GC B cells. It does so by controlling the expression of the Bcl6 and Obf1 genes. Furthermore, whereas transient induction of IRF4 in vivo was sufficient to induce GC B cells, sustained and higher concentrations of IRF4 promoted the generation of plasma cells while antagonizing the GC fate. To delineate IRF4 target genes and its modes of genomic interaction that are reflective of the GC or plasma cell programs, we performed chromatin immunoprecipitation sequencing (ChIP-seq) analysis by using an antigen-specific B cell culture system. Kinetic analysis of IRF4 binding to genomic sites, with or without its DNA partner PU.1, was correlated with changes in gene expression. Interestingly, IRF4 cotargeting with PU.1 at EICE motifs was associated with genes involved with B cell activation and the GC response. During these early stages of B cell activation, IRF4 targeting was also associated with AICE motifs. In striking contrast at a later stage, reflective of plasma cells, IRF4 targeting shifted to lower affinity ISRE motifs that enriched for genes involved in plasma cell differentiation. These results provide molecular insight into the concentrationdependent modes of IRF4 action in regulating the GC and PC programs of gene expression. Furthermore, they provide in vivo support for our model of ''kinetic control,'' which posits that the dynamics of accumulation of IRF4 in activated B cells regulate cell-fate outcomes during a humoral immune response.
RESULTS

IRF4 Regulates GC B Cell Differentiation
To analyze requirement of IRF4 in GC B cell responses, we generated mixed bone marrow chimeras with Irf4 +/+ and Irf4
progenitors (see Figure S1A available 1D ). The conditional Irf4 allele activates GFP expression concomitant with CRE-mediated deletion (Klein et al., 2006) . Staining of splenic tissue sections revealed that the few GCs developing in Irf4 fl/fl 3 CD19-Cre mice were GFP-negative, in contrast with their controls, demonstrating that these residual GCs were formed with B cells in which the Irf4 allele had not been deleted ( Figure 1D ). Thus, IRF4 plays an essential and cell-autonomous role in instructing GC B cell differentiation. (Figure 2A ; Figure S2B ). Because IRF4 is highly expressed in plasma cells, we confirmed that IRF4 hi Bcl6 À population represented plasma cells by their expression of cytoplasmic anti-HEL Ig and reduced B220 ( Figure S2C antigen and engaged T cell help as they underwent multiple cell divisions, albeit with reduced efficiency ( Figure S2D ) (Phan et al., 2005 between the GC B cell and plasma cell programs of gene expression. We then tested whether IRF4 was required for transcriptional activation of the Bcl6 and Pou2af1 genes. SW HEL responder cells were isolated 4.5 days following immunization ( Figure S2D ) and their transcripts analyzed by quantitative RT-PCR (qRT-PCR). Importantly expression of Bcl6 and Pou2af1 (encoding Obf1) were severely compromised in Irf4 À/À SW HEL B cells compared to their WT counterparts ( Figure 2B ). As expected, expression of the Aicda and Prdm1 genes were also impaired (Klein et al., 2006; Sciammas et al., 2006) . We note that Pax5 transcripts were comparable between Irf4 À/À SW HEL B cells and their WT counterparts ( Figure S2E ). Thus, the Bcl6 and Pou2af1 genes, which regulate GC B cell differentiation, are dependent on IRF4 for their induced expression in B cells upon antigen encounter in vivo.
IRF4 Regulates
Increased Antigen Affinity Favors Generation of IRF4
hi Plasma Cells Previously we have shown that increased antigen affinity augments BCR signaling-mediated expression of IRF4 and thus favors the generation of plasma cells at the expense of cells undergoing CSR in vitro . Given ability to analyze B cell dynamics in vivo on the basis of IRF4 and Bcl6 expression we tested whether varying antigen affinity in vivo had the predicted consequences on GC and plasma cell states. After adoptive transfer of SW HEL cells, we immunized with a series of HEL variants that exhibit a 10,000 fold range in affinity for the HyHEL10 BCR . The highest-affinity antigen led to an increased proportion of IRF4 hi Bcl6 À plasma cells (Figures 2C and 2D ; Figure S2F ). The enhancement in plasma cell generation was confirmed by HEL-specific ELISpot analysis (Figure 2E ; Figure S2G ). Thus, both in vitro as well as in vivo increasing the intensity of signaling through the BCR leads to greater expression of IRF4 and favors the generation of plasma cells.
Transient Expression of IRF4 Induces Generation of Bcl6 Expressing GC B Cells
To directly test consequences of manipulating IRF4 concentration on B cell-fate dynamics in vivo, we utilized a tet-inducible allele with the SW HEL transgenic system. This transgene is engineered to express IRF4 in a tetresponsive manner via the transcriptional activator (M2rtTA). The tet-inducible Irf4 and SW HEL transgenes were crossed onto the Irf4 À/À background so that the former functioned as the sole source of IRF4 protein in vivo ( Figure 3A doxycycline (DOX) either continuously (''sustained'') or just during the first two days after immunization (''pulsed''). Sustained Figure S3D ). We note that rescued B cells secreted HELspecific IgG demonstrating that sustained expression of IRF4 restored both CSR and secretory function ( Figure 3B; Figure S3D) . Importantly, transgenic expression of IRF4 also rescued the generation of Bcl6 + GC B cells ( Figure 3A ; Figure S3B and S3C). Strikingly, ''pulsed'' induction of IRF4 led only to the emergence of Bcl6 expressing GC B cells ( Figure 3A ; Figure S3B and S3C) that also expressed Aicda but not Pou2af1 transcripts ( Figure 3C ). Importantly, plasma cells did not develop under these conditions (Figure 3A and 3B; Figure S3D ). We note that the HEL-specific IgM spots observed with Irf4 À/À cells most likely emanate from host-derived B cells because they are also seen in mice immunized with mock-conjugated SRBC ( Figure S3D ; data not shown). and administered DOX in the drinking water ( Figure S3E ). Remarkably, SW HEL responders in the ''sustained'' DOX group were impaired in their ability to generate Bcl6 + cells ( Figure 3D ; Figures S3B and S3C ). DOX-mediated induction of the Irf4 transgene led to an increase in IRF4 hi expressing cells and was accompanied by a corresponding increase in HEL-specific plasma cells ( Figure 3E ; Figure S3H ). Interestingly, the increase in plasma cells was predominantly observed in the IgM class of HEL-specific cells ( Figure S3H ), as predicted by our model in which high IRF4 concentrations prevent durable AID expression. Thus transient induction of IRF4 is sufficient to induce the GC program. In contrast, sustained and higher concentrations of IRF4 terminate the GC program while promoting the generation of plasma cells.
Genomic Targeting Analysis of IRF4 and PU.1 in an Antigen-Dependent Differentiation System To gain insight into IRF4 regulation of distinct programs of B cell gene expression, we performed ChIP-seq analyses in an antigen-specific in vitro system that results in CSR and efficient plasma cell differentiation ( Figures S4A and S4B ) . IRF4 expression is induced under these conditions with BCR engagement and exhibits a wide range of cellular concentrations at day 1 ( Figure S4C ). By day 3, a bimodal pattern of IRF4 expression is observable with cells expressing either low or high concentrations of IRF4, which correspond to those undergoing CSR or differentiating into plasma cells, respectively (Sciammas et al., 2006 . We reasoned that kinetic analysis of the genome binding landscape of IRF4 in this cellular system might reveal a relationship between its differing concentrations and the regulation of distinct programs of gene expression. We note that these conditions do not promote the generation of GC B cells; however, given that AID is expressed and functions to promote SHM in these cells , we hypothesized that some molecular features of GC B cell To analyze distinct modes of IRF4 genome targeting, we performed parallel ChIPseq analyses with its major interaction partner, PU.1 (Eisenbeis et al., 1995) . This comparison enabled us to identify genomic regions that were targeted by IRF4 in conjunction with or in the absence of PU.1 (Figures S4A and S4D) . Table  S1 reports the details of sample processing with regard to sequencing, alignment and peak calls. The overall distribution of genomic sites of these two transcription factors is shown in Figure S4E and revealed that the majority of binding events were extragenic and occurred within 100 kbp of the nearest TSS. A small number of binding peaks were randomly chosen and validated by ChIP ( Figure S4F) .
To analyze the dynamics of IRF4 and PU.1 binding, we compiled coincident peaks between the day 1 and day 3 data sets ( Figure S4D ). Temporally-specific binding events were observed for both IRF4 and PU.1, suggesting that a shift in the genome binding landscape is associated with the bimodal expression of IRF4. Next, we determined the extent to which IRF4 targets the genome with or without PU.1 (Figures 4A and  4B ). IRF4 cobound with PU.1 at a majority of the genomic sites. A third of IRF4 binding events were not associated with PU.1; this mode of IRF4 genome targeting is denoted IRF4 (not PU.1). Comparison of our data with DNaseI seq analysis in naive B cells (ENCODE data, Figure S4G ) revealed $90% of IRF4 (and PU.1) cotargeted regions (days 1 and 3) to be contained within DNaseI hypersensitive sites in naive B cells demonstrating that EICE motifs are located in accessible chromatin. In contrast, IRF4 (not PU.1) regions overlapped with %50% of the DNaseI sites present in naive B cells suggesting that this mode of IRF4 genomic targeting involved the de novo establishment of accessible regions.
Distinct DNA Motifs Comprise the IRF4 Cistrome
We searched for overrepresented sequence motifs by using the MEME pattern-finding algorithm in the IRF4 cistrome ( Figures 4A  and 4B ). Within the IRF4 (and PU.1) bound regions, the EICE motif occurred with an incidence approaching 100%. This finding demonstrated the fundamental importance of the EICE motif in recruitment of IRF4 by PU.1 to genomic sites in differentiating B cells.
In contrast, within IRF4 (not PU.1)-bound regions, two distinct DNA motifs were enriched ( Figure 4B ). The first represented the ISRE, which is composed of two IRF motifs (GAAA) separated by two base pairs. The second motif was a canonical AP-1 motif that was often found near the peak's summit ( Figure S4I ). Inspection of the surrounding sequences identified an IRF motif (GAAA) either abutting or separated by four nucleotides from the AP-1 motif ( Figure 4B ; Figure S4H ) suggesting the presence of an AP-1-IRF composite element (AICE) (Glasmacher et al., 2012) . Accordingly, we found that BATF and IRF4 cobound to a sampling of these AICE motifs in B cells ( Figure S4K) . Thus, the IRF4 cistrome in B cells comprises three distinct DNA binding modes characterized by EICE, AICE, and ISRE motifs.
Within the IRF4 (not PU.1) peaks, the incidence of AICE and ISRE motifs was inverted between the day 1 and day 3 time points, and the ISRE predominated at day 3 ( Figure 4B ). This demonstrates that the nature of the IRF4 binding landscape shifts during the process of B cell differentiation, and the higher concentration of IRF4 is accompanied by increased occupancy of ISRE motifs.
IRF4 Binds the ISRE as a Dimer with Lower Affinity
Given the above finding, we analyzed the relative affinity of IRF4 for the ISRE and EICE motifs. An ISRE motif from Prdm1 CNS9 (Sciammas et al., 2006) was used in electrophoretic mobility shift assays (EMSAs) ( Figure 4C ). IRF4 generated a protein-DNA complex ( Figure 4C ) that was competed by WT competitor DNA, but not ones in which one or both of the IRF sites were mutated. This suggested that IRF4 bound the ISRE as a dimer, which was confirmed by analyzing the migration of the protein-DNA complexes formed by mixing two different carboxy-terminal truncations of IRF4 ( Figure S4J ). Thus IRF4 binds the ISRE as a homodimer in contrast with its binding to an EICE as a heterodimer with PU.1 or to an AICE as a heterotrimer with a BATFcontaining AP-1 complex.
To determine the relative affinity of IRF4-PU.1 heterodimeric or IRF4 homodimeric complexes for the EICE versus ISRE motifs, respectively, we analyzed binding over a wide range of IRF4 concentrations ( Figures 4D and 4E) . Whereas increasing IRF4 concentration in the presence of PU.1 resulted in saturation of IRF4 binding to the EICE, saturation was not observed for IRF4 binding (in the absence of PU.1) to the ISRE within the concentration range that was tested. These data demonstrated that IRF4 binds with higher affinity to EICE motifs as a heterodimer with PU.1 than to ISRE motifs as a homodimer and suggest that IRF4 is able to occupy EICE motifs at a lower concentration in vivo. Thus, higher IRF4 concentrations would be needed to drive binding onto ISRE motifs, and this is consistent with their increased utilization in differentiating IRF4
hi B cells at day 3 (Figure 4B ; Figure S4C ).
IRF4 Targeting of the Prdm1 Locus
Our previous analysis had suggested that IRF4 directly activates Prdm1 transcription to enable plasma cell differentiation. The ChIP-seq analysis confirmed that IRF4 bound to the CNS9 region in Prdm1 ( Figure 5A ; Figure S5A ). In addition, we identified multiple peaks surrounding the Prdm1 gene that increased in intensity at day 3 ( Figure S5A ). Because IRF4 is necessary for promoting Blimp1 expression, we reasoned that IRF4 binding to the Prdm1 locus may be required for the deposition of activating H3K4me1 and H3K27Ac chromatin marks. Analysis of WT B cells showed that these chromatin marks were present at low levels at some of these regions at the day 0 and day 1 time points but sharply increased at day 3 when Prdm1 was maximally expressed ( Figure S5B ). In the absence of IRF4, these marks failed to accumulate not only at IRF4-targeted but also at nontargeted regions that included the Prdm1 promoters ( Figure S5C ). Overall, this analysis demonstrates an extensive targeting landscape of IRF4 at the Prdm1 locus that includes both IRF4 (and PU.1) and IRF4 (not PU.1) binding modes. Importantly IRF4 binding to multiple sites at the Prdm1 locus appears to be required for the acquisition of an activated chromatin state.
IRF4 Targeting of Bcl6 and Pou2af1 Loci
Because Bcl6 and Pou2af1 expression is also dependent on IRF4, we sought to determine whether it targeted these genes.
Immunity
IRF4 Regulates GC B Cell-Fate Dynamics IRF4 bound to a region $24 kbp upstream of the Bcl6 gene (Fig- ure 5B) and to several sites within the first intron. Notably, at the upstream position, PU.1 was found to cobind with IRF4 and this region coincided with a DNaseI hypersensitive site ( Figure 5B ; Figure S5D ). We did not find evidence of IRF4 targeting the Bcl6 promoter as was shown in human B lymphoma cell lines (Saito et al., 2007) . There were two prominent IRF4 (not PU.1) peaks within the first intron of Pou2af1 gene ( Figure 5C ). IRF4 binding to sites in the Bcl6 and Pou2af1 genes diminished from day 1 to day 3 of B cell activation as compared with its occupancy of the Prdm1 locus, which underwent an increase. To confirm targeting of the Bcl6 and Pou2af1 genes by IRF4 in GC B cells, we performed ChIP analysis with such cells isolated from immunized mice. We observed binding of IRF4 to the aforementioned regions of the Bcl6 and Pou2af1 genes ( Figure 5D ). Thus these data, along with those in Figure 2B , demonstrate that IRF4 directly targets and activates the expression of key regulatory genes that are required for GC B cell differentiation. background. We reasoned that we could relate distinct patterns of gene expression to divergent modes of IRF4 genome targeting by analyzing the expression changes between cellular conditions in which IRF4 is expressed to varying extents at the different time points. To this end, we employed Expectation Maximization of Binding and Expression Profiles (EMBER) (Maienschein-Cline et al., 2011) , which uses an unsupervised machine learning algorithm to infer target genes from transcription factor binding and expression data. EMBER scores genes that are likely regulated by a given transcription factor within 100 kpb of its binding peaks based on their conforming to an overrepresented gene expression pattern (see Supplemental Information for further details).
We applied EMBER to the IRF4 (and PU.1) and IRF4 (not PU.1) peaks at the day 1 and day 3 time points ( Figures 4A and 4B ). The EMBER analysis is shown in Figure 6A and Table S2 . The numbers in the upper left hand boxes of each graph indicate the number of peaks that were assigned at least one target gene ( Figure 6A ). Roughly half of all genome targeting events (compare to the number of peaks in Figures 4A and 4B ) scored above a statistical threshold (see Supplemental Information). To simplify analysis of the gene expression data, we binned differential expression between pairwise sample comparisons into five categories: (++) large upregulation, (+) small upregulation, (0) no change, (-) small downregulation, and (--) large downregulation (see Supplemental Information). Each of the pairwise gene expression comparisons are plotted against the log-likelihood ratio of finding a given differential expression pattern. IRF4 peak-associated trends in differential gene expression are represented as changes in the relative sizes of colored bars corresponding to each of the five bins of differential expression. For example, in Figure 6A , in the IRF4 (and PU.1) day 1 expression pattern (top left), the large bright green bars in the fourth, fifth, and sixth columns indicate that the majority of inferred target genes tend to be strongly downregulated in the presence of IRF4 (either in WT cells or in Irf4 À/À cells after restoration of IRF4 expression with DOX). Conversely, the much smaller red bars in the same columns indicate that very few of the inferred gene targets are strongly upregulated in the presence of IRF4. EMBER analysis revealed three dominant patterns of transcriptional control by IRF4 (and PU.1) binding versus IRF4 (not PU.1) binding events ( Figure 6A ). In the first pattern, inferred target genes associated with IRF4 (and PU.1) binding tended to be repressed regardless of time point (the green bars corresponding to mild and strong repression are large). This unexpected finding is consistent with an IRF4-dependent manner of regulation because (1) these genes were derepressed in the absence of IRF4 and (2) the same genes were repressed when IRF4 expression was restored by DOX-mediated induction of the inducible allele of Irf4 in Irf4 À/À B cells ( Figure 6A ). In the second pattern, genes associated with IRF4 (not PU.1) binding were preferentially activated at day 1. The third pattern comprises a mixture of up-and downregulated targets of IRF4 (not PU.1) on day 3. We note that the transition in the nature of transcriptional output accompanies both the change in IRF4 concentration ( Figure S4C ) as well as the differentiation state of these cells ( Figure S4B) . Collectively, this analysis shows that IRF4 (not PU.1) genome targeting, regardless of time, is associated with markedly different behaviors of gene expression compared to those associated with IRF4 (and PU.1) genome targeting, suggesting that each binding mode functions to control distinct developmental programs.
Divergent IRF4 Binding Modes Correlate with Distinct Developmental Programs
To substantiate the hypothesis that IRF4 (and PU.1) and IRF4 (not PU.1) modes of genome targeting regulate different developmental programs, we tested whether the expression patterns of inferred target genes obtained from differentiated cells at the day 3 time point correlated with plasma cell or GC B cell states. To perform this analysis, we used transcriptome experiments derived from ex vivo sorted antigen-specific plasma cells and GC B cells (Luckey et al., 2006) . By using these data from GEO, we compared GC B cell and plasma cell transcriptomes and classified differential gene expression by using the same discrete binning scheme as above (++, +, 0, -, --). Then, by using inferred target genes from either IRF4 (and PU.1) or IRF4 (not PU.1) day 3 peaks, we computed the log odds ratio of finding preferential expression of these genes in plasma cells or GC B cells ( Figure 6B ; Figure S6A ; Table S2 ).
With some exceptions, we found that the majority of IRF4 (and PU.1) inferred target genes were expressed at lower levels in plasma cells compared to GC B cells (large yellow bar). In contrast, inferred target genes associated with IRF4 (not PU.1) binding at day 3 enriched for a substantial set of genes that were expressed at higher levels in plasma cells compared to GC B cells (large bright blue bar). Similar trends were observed when we analyzed the naive to GC B cell and the naive to plasma cell transitions ( Figures S6B and S6C ). These data indicate that, during the transition of a naive or GC B cell to a plasma cell, both IRF4 (and PU.1) and IRF4 (not PU.1) binding events are associated with the repression of GC genes. In contrast, IRF4 (not PU.1) binding, particularly to the ISRE motif seems to preferentially function in activation of the PC program of gene expression. The proposed functions of these distinct modes of IRF4 genome targeting in relation to its intracellular concentrations and B cell fate dynamics are depicted in Figure S7 .
To further corroborate the finding that each binding mode is controlling distinct developmental programs, we determined whether the inferred target genes controlled by IRF4 (and PU.1) and IRF4 (not PU.1) genome targeting were associated with different functional classes of genes. Whereas genes associated with IRF4 (and PU.1) binding enriched for immune and inflammatory response categories, the IRF4 (not PU.1)-associated genes enriched for cell biological categories including endoplasmic reticulum functions ( Figure S6D ; Table S3 ). Many of these latter genes are important for the differentiation of specialized secretory cells suggesting that the IRF4 (not PU.1) targeting mode involving ISREs specifies the functional state of plasma cells.
DISCUSSION
We have demonstrated an essential and cell-intrinsic role for IRF4 in generating GC B cells. IRF4 does so in part by activating expression of the Bcl6 and Pou2af1 genes. Our combined genetic analyses involving conditional deletion of the Irf4 gene prior to B cell activation as well as its transient expression by using the Irf4-inducible allele define the temporal requirement for IRF4 in promoting GC B cell fate to the first few days after antigen encounter. The results strongly suggest that IRF4 is required for initiation, but not maintenance of the GC state, and the latter is dependent on sustained expression of Bcl6. It follows that IRF4 is required for the activation but not maintenance of expression of the Bcl6 gene. In contrast, expression of the Pou2af1 gene appears to continuously depend upon IRF4. Intriguingly, the latter gene along with IRF4 also functions in regulating plasma cell differentiation (Corcoran et al., 2005) . Given that high and sustained expression of IRF4 antagonizes the GC state, these findings account for transient action of IRF4 in generating GC B cells and its downregulation in such cells. It will be interesting to determine whether in GC B cells negative feedback by Bcl6 serves to directly repress the Irf4 gene, as has been observed in cell lines (Alinikula et al., 2011) . Our key conclusion that IRF4 functions in a cell-intrinsic manner to regulate GC B cell differentiation differs from that reached by a recent report (Bollig et al., 2012) . We note that our findings are based on the use of three distinct alleles of Irf4: germline, conditional, and tet-inducible. Importantly, the Irf4-conditional allele (Irf4 fl/fl ) displays a GC B cell defect when CRE expression is driven by the CD19 locus but not by the Cg1 locus. Finally, the tet- By using genome-wide analysis in a model system involving antigen-dependent B cell differentiation, three distinct modes of IRF4 binding to its target sequences have been delineated. The dominant mode (representing two thirds of the total) involves cobinding of IRF4 with PU.1 to EICE motifs. Two additional modes, both of which are PU.1 independent, involve IRF4 binding to either an ISRE or AICE motif. Co-occupancy of the EICE motif by PU.1 and IRF4 is associated with regulation of genes involved in B cell activation and function. Molecular redundancy between PU.1 and SpiB in the Ets family, as well as between IRF4 and IRF8 in the IRF family, can result in the targeting of the EICE motif by four distinct Ets-IRF ternary complexes (Eisenbeis et al., 1995) . Accordingly, these complexes can play either redundant or unique roles in B cell development, activation, and terminal differentiation. Importantly, although IRF4 and IRF8 function redundantly in the differentiation of pre-B cells (Lu et al., 2003) , IRF4 is uniquely required for the GC response and plasma cell differentiation (Feng et al., 2011; Klein et al., 2006; Sciammas et al., 2006) . Given that SpiB is uniquely important for the differentiation of GC B cells along with the observation that IRF8 is expressed at high levels in GC B cells, it will be interesting to determine whether occupancy of the EICE motif in this cellular context shifts to these factors.
A second mode of IRF4 binding is observed on composite AP-1-IRF motifs (AICE). This unusual motif has been observed by us in the context of T cells, where it functions as the dominant mode of IRF4 genomic targeting, given that these cells do not express PU.1 or SpiB (Glasmacher et al., 2012) . We have demonstrated that this composite motif directs cooperative binding of IRF4 with BATF heterodimers belonging to the AP-1 family. As Batf À/À B cells partially phenocopy Irf4 À/À B cells (Betz et al., 2010; Ise et al., 2011) , it will be informative to analyze the molecular consequences of IRF4-BATF family complexes that assemble on AICE motif-containing genes. In accord with a signal-dependent mode of gene regulation by AP-1 family members, the AICE motif is observed at high incidence in DNA bound regions at the day 1 time point, soon after BCR signaling initiated by antigen encounter. At this time point, B cells are forming blasts and initiating the gene regulatory programs necessary for subsequent differentiation. The integration of IRF4 with the AP-1 system at this stage, both of which are controlled by BCR signaling, suggests that they could be important for effecting the downstream transcriptional responses that are triggered by differential BCR signaling; i.e., low-or high-affinity antigen or levels of coreceptor engagement. The third mode of IRF4 binding in the B cell genome involves classical ISREs. We demonstrate that IRF4 binds the ISRE as a homodimer, and this interaction is of lower affinity than the PU.1-IRF4 interaction with the EICE motif. Accordingly, binding to the ISRE is preferentially observed at the day 3 time point of B cell differentiation when IRF4 protein levels peak. The day 3 time point represents a stage where a majority of the B cells in the culture system have undergone differentiation into plasma cells. Intriguingly, the increased usage of the ISRE in plasma cells suggests an association of this regulatory element with structural genes important for their differentiation. Indeed, such target genes are enriched for those that encode secretory functions. Although the concept of differing concentrations of a transcription factor regulating distinct cell fates has been suggested to be widely operative in mammalian cell differentiation (see DeKoter and Singh, 2000) , its molecular basis has proven difficult to elucidate. Our results provide an appealing molecular explanation for the requirement of higher concentrations of IRF4 in regulating plasma cell differentiation by enabling occupancy of low affinity ISRE motifs that are associated with plasma cell genes.
Based on experimental and mathematical analyses, we have proposed a mechanism of kinetic control in which the initial rate of IRF4 accumulation, driven by the strength of BCR signaling, controls a gene regulatory network that orchestrates cell fate decisions between cells undergoing CSR, a ''GC-like'' state, versus cells differentiating into plasma cells . In this model, low affinity or avidity antigen interactions with the BCR favor a longer duration of a ''GC-like'' state before plasma cell differentiation. In contrast, high affinity or avidity antigen interactions with the BCR limit the period of time in which AID is expressed and therefore promote plasma cell generation accompanied with relatively low levels of CSR and SHM. Herein, we corroborate and extend this regulatory model. Specifically, as evidenced by the ''pulsed'' experiment, we propose that transient expression of IRF4 in GC B cells (IRF4 lo Bcl6 + ) serves to ''reset'' the mechanism of kinetic control initiated by the first exposure to antigen. Hence, kinetic control would be reinstated during positive selection of somatically hypermutated GC B cells upon their interaction with antigen displayed by follicular dendritic cells. Specifically, those clones accumulating mutations that confer higher affinity to their BCR would induce increased levels of IRF4 expression, both as a function of BCR signaling and CD40 signaling by T helper cells, and thus differentiate into plasma cells. In support of this notion, it has been found that post-GC plasma cells are preferentially enriched for high affinity SHM-dependent mutations Smith et al., 1997) . In contrast, those clonotypes exhibiting lower affinity conferring mutations would induce lower levels of IRF4 expression and differentiate into memory B cells or undergo new rounds of SHM and selection (Smith et al., 1997; Victora et al., 2010) . Given that GC B cells express high amounts of Bcl6, it will be interesting to determine whether selection into the high affinity cell pool involves a steeper magnitude of IRF4 induction to overcome repression by Bcl6.
